Reassessing Twenty Years of Vaccine Development Against Tuberculosis

Released on by Ulrich E. Schaible
preview-18

  • Reassessing Twenty Years of Vaccine Development Against Tuberculosis Book Detail

  • Author : Ulrich E. Schaible
  • Release Date : 2018-03-23
  • Publisher : Frontiers Media SA
  • Genre :
  • Pages : 110
  • ISBN 13 : 2889454460
  • File Size : 70,70 MB
DOWNLOAD BOOK

Reassessing Twenty Years of Vaccine Development Against Tuberculosis by Ulrich E. Schaible PDF Summary

Book Description: Tuberculosis (TB) remains the prime bacterial infection worldwide with 10.4 million infections and a death toll of 1.7 million people in 2016 according to WHO statistics. Tuberculosis is caused by members of the Mycobacterium tuberculosis complex, facultative intracellular bacteria able to thrive within otherwise potent innate defense cells, the macrophages. In a world of increasing numbers of infections with drug resistant M. tuberculosis strains, the daunting race between developing new therapeutics and emerging resistant strains will hardly produce a winner. This cycle can only be broken by enhancing population wide immune control through a better vaccine as the only one currently in use, M. bovis Bacillus Calmette Guerin (BCG). The protective efficacy of BCG against pulmonary tuberculosis in all age groups is dissatisfying and geographically highly diverse with the tropical areas showing the lowest efficacy rates. Despite worldwide vaccination coverage, the impact of BCG on the steep decrease of tuberculosis incidence rates in the developed world seems therefore questionable and can rather be attributed to improved social, housing and nutritional conditions, better health care, surveillance and treatment systems. The last 15 years saw tremendous efforts to improve vaccination strategies against tuberculosis. Different paths of vaccine approaches were followed including genetically improved BCG strains, attenuated M. tuberculosis variants, recombinant viral vectors and subunit vaccine candidates combined with novel more potent adjuvants. With the first novel vaccine candidates being evaluated in clinical phases II and III and initial results chastening the expectations, a critical reassessment of all candidates is inevitable. Here, we assembled experts to review and assess the current status of novel anti-tuberculosis vaccine candidates, their efficacy and prospects for implementation as well as the pitfalls and possible measures for improvement.

Disclaimer: www.yourbookbest.com does not own Reassessing Twenty Years of Vaccine Development Against Tuberculosis books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

Priorities for the National Vaccine Plan

Priorities for the National Vaccine Plan

File Size : 69,69 MB
Total View : 9725 Views
DOWNLOAD

Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic dec

Global Tuberculosis Report 2019

Global Tuberculosis Report 2019

File Size : 98,98 MB
Total View : 7804 Views
DOWNLOAD

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemi

Handbook of Global Tuberculosis Control

Handbook of Global Tuberculosis Control

File Size : 8,8 MB
Total View : 7175 Views
DOWNLOAD

This ambitious reference surveys worldwide efforts at controlling the spread of tuberculosis, with special emphasis on the developing world. Case studies from C